These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 24845379
1. Upregulation of tumor necrosis factor-alpha in nucleus accumbens attenuates morphine-induced rewarding in a neuropathic pain model. Wu Y, Na X, Zang Y, Cui Y, Xin W, Pang R, Zhou L, Wei X, Li Y, Liu X. Biochem Biophys Res Commun; 2014 Jul 11; 449(4):502-7. PubMed ID: 24845379 [Abstract] [Full Text] [Related]
3. Distinct role of tumor necrosis factor receptor subtypes 1 and 2 in the red nucleus in the development of neuropathic pain. Zeng XY, Zhang Q, Wang J, Yu J, Han SP, Wang JY. Neurosci Lett; 2014 May 21; 569():43-8. PubMed ID: 24686175 [Abstract] [Full Text] [Related]
4. Dynamic changes of tyrosine hydroxylase and dopamine concentrations in the ventral tegmental area-nucleus accumbens projection during the expression of morphine-induced conditioned place preference in rats. Liang J, Ma SS, Li YJ, Ping XJ, Hu L, Cui CL. Neurochem Res; 2012 Jul 21; 37(7):1482-9. PubMed ID: 22396106 [Abstract] [Full Text] [Related]
5. Direct evidence for the involvement of endogenous beta-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state. Niikura K, Narita M, Narita M, Nakamura A, Okutsu D, Ozeki A, Kurahashi K, Kobayashi Y, Suzuki M, Suzuki T. Neurosci Lett; 2008 Apr 25; 435(3):257-62. PubMed ID: 18359165 [Abstract] [Full Text] [Related]
6. Changes in morphine reward in a model of neuropathic pain. Cahill CM, Xue L, Grenier P, Magnussen C, Lecour S, Olmstead MC. Behav Pharmacol; 2013 Jun 25; 24(3):207-13. PubMed ID: 23591124 [Abstract] [Full Text] [Related]
7. Systemic tumor necrosis factor-alpha decreases brain stimulation reward and increases metabolites of serotonin and dopamine in the nucleus accumbens of mice. van Heesch F, Prins J, Korte-Bouws GA, Westphal KG, Lemstra S, Olivier B, Kraneveld AD, Korte SM. Behav Brain Res; 2013 Sep 15; 253():191-5. PubMed ID: 23896053 [Abstract] [Full Text] [Related]
8. Intrathecal ultra-low dose naloxone enhances the antihyperalgesic effects of morphine and attenuates tumor necrosis factor-α and tumor necrosis factor-α receptor 1 expression in the dorsal horn of rats with partial sciatic nerve transection. Yang CP, Cherng CH, Wu CT, Huang HY, Tao PL, Lee SO, Wong CS. Anesth Analg; 2013 Dec 15; 117(6):1493-502. PubMed ID: 24257399 [Abstract] [Full Text] [Related]
9. Endogenous histamine inhibits the development of morphine-induced conditioned place preference. Gong YX, Lv M, Zhu YP, Zhu YY, Wei EQ, Shi H, Zeng QL, Chen Z. Acta Pharmacol Sin; 2007 Jan 15; 28(1):10-8. PubMed ID: 17184577 [Abstract] [Full Text] [Related]
10. Dynamic distributions of tumor necrosis factor-alpha and its receptors in the red nucleus of rats with spared nerve injury. Wang J, Ding CP, Yu J, Zeng XY, Han SP, Wang JY. Neuropathology; 2016 Aug 15; 36(4):346-53. PubMed ID: 26669937 [Abstract] [Full Text] [Related]
12. Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain. Sagheddu C, Aroni S, De Felice M, Lecca S, Luchicchi A, Melis M, Muntoni AL, Romano R, Palazzo E, Guida F, Maione S, Pistis M. Neuropharmacology; 2015 Oct 15; 97():383-93. PubMed ID: 26113399 [Abstract] [Full Text] [Related]